Ludmila A Barnakova

Title: Ludmila A Barnakova: Innovator in Reversible Covalent Bond Research

Introduction

Ludmila A Barnakova is a prominent inventor based in Downingtown, PA (US). She has made significant contributions to the field of drug design, particularly in the area of reversible covalent bonds. With a total of three patents to her name, her work has the potential to impact the development of new therapeutic agents.

Latest Patents

Barnakova's latest patents include innovative methods to measure dissociation rates for ligands that form reversible covalent bonds. One of her notable patents details the crystal structure of the ligand binding domain of ERR-α in complex with a ligand that forms a reversible thioether bond to Cys325 of ERR-α. These methods provide a novel molecular mechanism for modulating the activity of ERR-α and lay the groundwork for rational drug design aimed at creating potent specific ligands for this new drug target.

Career Highlights

Ludmila A Barnakova is currently employed at Janssen Pharmaceutica NV, where she continues her research and development efforts. Her work focuses on advancing the understanding of reversible covalent bonds and their applications in drug modulation.

Collaborations

Barnakova collaborates with esteemed colleagues such as Dionisios Rentzeperis and Marta Cristina Abad. These partnerships enhance her research and contribute to the innovative solutions being developed in her field.

Conclusion

Ludmila A Barnakova is a trailblazer in the realm of reversible covalent bond research, with her patents paving the way for future advancements in drug design. Her contributions are vital to the ongoing evolution of therapeutic strategies.